Clinical Trial Signals · weekly
Newly posted recruiting studies with US sites, every week.
Studies first posted on ClinicalTrials.gov in the past week that are recruiting now, grouped by state and lead sponsor, with the site, phase, conditions and a link to each record.
Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.
- Minnesota
- Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesPhase 2Aclaris Therapeutics, Inc. · New Brighton
- Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryPhase 2HealthPartners Institute · Saint Paul
- Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialPhase 3Mayo Clinic · Albert Lea
- Florida
- Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyPhase 1H. Lee Moffitt Cancer Center and Research Institute · Tampa
What's newly recruiting, sorted the way you staff it.
Only what's new
Studies first posted in the past week that are recruiting now and have at least one US recruiting site.
By state, then sponsor
Each recruiting site sits under its state and lead sponsor, with facility, city, phase and conditions.
From the public record
Source: ClinicalTrials.gov. We show the registry's data timestamp and our processing date. No names, phones or emails from study records.
This week's list, shortened
Nov 13–20: 39 newly posted recruiting studies, 51 US recruiting sites across 24 states, 38 lead sponsors. Below are real rows from that build.
- Window
- First posted Nov 13–20, 2026
- Delivery
- Every Monday by 8am ET by default, or a weekday you choose
- Source
- ClinicalTrials.gov public records; no personal contact data
| Study | Phase | Conditions | Recruiting site | First posted | Site status |
|---|---|---|---|---|---|
| Minnesota6 sites | |||||
| Aclaris Therapeutics, Inc. | |||||
| Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesNCT07935590 | Phase 2 | Lichen Planus | Aclaris Clinical SiteNew Brighton | Nov 13 | Recruiting |
| HealthPartners Institute | |||||
| Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryNCT07935278 | Phase 2 | Concussion (Diagnosis), Mild Traumatic Brain Injury | HealthPartners Neuroscience CenterSaint Paul | Nov 13 | Recruiting |
| Mayo Clinic | |||||
| Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialNCT07935889 | Phase 3 | Glioblastoma, IDH-Wildtype | Mayo Clinic Health System in Albert LeaAlbert Lea | Nov 13 | Recruiting |
| Mayo Clinic Health Systems-MankatoMankato | Nov 13 | Recruiting | |||
| Mayo Clinic Radiation Therapy - NorthfieldNorthfield | Nov 13 | Recruiting | |||
| Mayo Clinic in RochesterRochester | Nov 13 | Recruiting | |||
| Florida5 sites | |||||
| H. Lee Moffitt Cancer Center and Research Institute | |||||
| Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyNCT07940738 | Phase 1 | Hematologic Malignancy | Moffitt Cancer CenterTampa | Nov 17 | Recruiting |
| RAI Services Company | |||||
| Vuse Pro Puffing Topography Study in Adult SmokersNCT07938320 | Not applicable | Smoking, Tobacco | WACDoral | Nov 16 | Recruiting |
| L&E Research TampaTampa | Nov 16 | Recruiting | |||
| Trevi Therapeutics | |||||
| A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsNCT07946575 | Phase 1 | Healthy Participants | Clinical Pharmacology of Miami, LLCMiami | Nov 18 | Recruiting |
| University of Florida | |||||
| RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors - High Grade GliomaNCT07949071 | Phase 1, Phase 2 | Recurrent High-grade Glioma | UF HealthGainesville | Nov 19 | Recruiting |
| Texas5 sites | |||||
| Carnegie Mellon University | |||||
| AI-Driven Hip Exoskeleton Control for Diverse Users and Walking TasksNCT07940127 | Not applicable | Healthy Volunteers, Gait … | University of Texas at AustinAustin | Nov 16 | Recruiting |
| + 4 more sites in this state in the full list | |||||
Showing 12 of 51 US recruiting sites. We don't yet claim a study changed status or added a site this week; those checks start once weekly snapshots can be compared.
Data from ClinicalTrials.gov, a U.S. government database. Registry data timestamp: Nov 20, 2026, 10:00:05 (as published; the field has no time zone). Processed: Nov 20, 2026, 12:54 PM ET. EnrollFeed is not affiliated with or endorsed by ClinicalTrials.gov, NLM or NIH. Sponsors and investigators are responsible for each record; check the NCT link for the current version.
Simple monthly pricing
No free tier. We charge for curation, timing and delivery, not for the ClinicalTrials.gov records. Cancel by replying to the email or your receipt.
Individual
One recipient.
- The weekly list, every Monday by 8am ET or a weekday you choose
- Grouped by state and lead sponsor, with a link to each NCT record
- Data timestamp and processing date on every issue
Checkout opens once terms are final
Team
Up to 3 people at one organization.
- Everything in Individual
- Up to 3 recipients
Checkout opens once terms are final
Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.
Questions
What is in the digest?
Studies first posted on ClinicalTrials.gov in the past week that are currently recruiting and have at least one US recruiting site, with facility, city, state, phase, conditions, sponsor and a link to the study record.
Does “newly posted” mean the study just started recruiting or added a site?
No. It means the study record was first posted in the past week and is now recruiting. Status changes and new sites will be listed only after we can compare weekly snapshots.
Where does the data come from?
ClinicalTrials.gov, a U.S. government database. The sponsor or investigator is responsible for the accuracy of each record. This product is not affiliated with or endorsed by NIH, NLM, or ClinicalTrials.gov.
Do you include investigator or site contact details?
No. We do not include names, phone numbers or email addresses from the study records.
When is it delivered?
Every Monday by 8am ET by default, or on another weekday you choose.
How much does it cost?
$149 per month. There is no free tier. You can ask for a free one-week sample by emailing hello@enrollfeed.com.